The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Moving from software into biotech leadership is possible, but a technology background does not replace scientific learning. Four executives profiled by GeekWire in September 2021—Sujal Patel, Daphne Koller, Naveen Jain and Terry Myerson—described different ways to build biological knowledge, collaborate with experts and adapt to the demands of life-sciences businesses. Their experiences point to practical lessons, not a universal career formula.
Four different routes from technology to life sciences
GeekWire’s September 2, 2021 feature followed four leaders whose earlier careers were rooted in software or technology. The company roles and descriptions below reflect that article’s reporting at the time; they should not be read as confirmation of current positions or company offerings.
| # | Preview | Product | Price | |
|---|---|---|---|---|
| 1 |
|
Biotechnology for Beginners | $28.52 | Buy on Amazon |
| 2 |
|
Biotechnology Demystified | $20.36 | Buy on Amazon |
| 3 |
|
Biotechnology for Beginners | $132.98 | Buy on Amazon |
| 4 |
|
Biotechnology | $103.82 | Buy on Amazon |
| 5 |
|
Superconvergence: How the Genetics, Biotech, and AI Revolutions Will Transform our Lives, Work, and... | $14.80 | Buy on Amazon |
| Leader | Technology background | Life-sciences role described in 2021 | Emphasis in the transition |
|---|---|---|---|
| Sujal Patel | Helped launch and lead Isilon Systems, which GeekWire reported sold to EMC for $2.25 billion in 2010. | Co-founded Nautilus Biotechnology with Stanford associate professor Parag Mallick in 2016. The company was described as combining computer science, biochemistry and nanotechnology to analyze proteins. | Learn biology and chemistry while contributing directly to technical work. |
| Daphne Koller | Computer scientist, Stanford professor for 18 years and Coursera co-founder. | Founded insitro in 2018 as a drug-discovery company bringing machine learning and biology together. | Approach biology with humility and build a culture of mutual respect across disciplines. |
| Naveen Jain | Founder and former CEO of InfoSpace; the article described Viome as his seventh venture. | Viome Life Sciences was described as analyzing the microbiome and offering personalized probiotics and supplements, alongside a medical-diagnostics division. | Keep learning the science and design the business around the consumer experience. |
| Terry Myerson | Former Microsoft executive who led Windows and Devices. | Tapped to lead Truveta in 2020. GeekWire described it as aggregating medical-records data to connect treatments with outcomes and underlying health. | Treat patient-data ethics, privacy, security and quality as core responsibilities. |
How to learn biology without pretending to be a biologist
Patel: combine study with hands-on technical work
After leaving Isilon, Patel spent four years investing and taking board seats before returning to an operating role. He told GeekWire that his first year at Nautilus included substantial coding on a second-generation algorithm based on Mallick’s work, while he worked to catch up on biology and chemistry.
His learning sequence was practical: he used college-level classes available on YouTube, asked Mallick questions regularly, and read research papers in the company’s core areas before it began building a lab. Patel summarized the adjustment this way: “I had to basically catch up and figure out how to be a CEO of biotech.” The useful lesson is not that online classes alone qualify someone to lead a scientific company; it is that technical contribution can proceed alongside deliberate study and ongoing access to scientific expertise.
#1 Best Overall
- New
- Mint Condition
- Dispatch same day for order received before 12 noon
- Guaranteed packaging
- No quibbles returns
Koller: take classes, read papers carefully and ask questions
Koller said she had little recent formal biology education and initially found research papers difficult to understand. Her advice was to take biology classes where possible, look up unfamiliar terms, and ask biology colleagues questions rather than treating scientific writing as immediately accessible.
“The most important thing is to be courageous and humble at the same time,” she said. She also put the learning challenge plainly: “biology is hard, you need to learn it.” Her warning applied in both directions: technologists should not assume software or machine learning can simply conquer biology, while biologists should not dismiss technology leaders as incapable of making a scientific contribution.
Rank #2
Build around complementary expertise, not a technology-versus-science contest
These accounts describe different ways of combining technical and biological skills. Patel worked on an algorithm while learning from a scientific co-founder. Koller emphasized a culture where people from both fields could contribute without dismissing one another. GeekWire also quoted Madrona Venture Group managing director Matt McIlwain on the potential of the intersection: “Part of that allows you to think about the science and the product differently.”
For an aspiring founder or executive, the practical implication is to identify what the business actually needs from each discipline. Computing and machine learning may shape how data are handled or how a product is developed, but a life-sciences company still depends on biological and medical knowledge. The profiles offer no basis for treating one person’s learning route, or a fixed mix of technical and scientific hires, as the right model for every company.
Do these 3 things before closing this tab:
1Clear out junk files and repair common Windows errors2Scan for outdated or missing drivers - takes under a minute3Repair Windows errors before they cause bigger problemsRank #3
Keep the customer experience and the scientific claim distinct
Jain urged founders to keep reading scientific papers to learn the field’s vocabulary and to think like consumers when designing a business. He used Viome’s customized supplement packaging as an example of consumer-facing design, saying: “From a business standpoint, collecting this massive amount of data, you have to think about it very differently, you have to think like a consumer.”
GeekWire’s description of Viome’s microbiome services and supplements reports what the company was doing as described in 2021; it is not evidence that microbiome testing, supplements or any particular product is effective or appropriate for an individual. Consumer-friendly packaging and a compelling service experience are separate questions from whether a health-related claim is supported.
Rank #4
Patient-data businesses carry obligations beyond ordinary product design
Myerson’s account highlights a different challenge from learning biology or designing for consumers. Truveta was described as working with medical-records data, where privacy, security, ethics and data quality are central to whether the work is trustworthy. “You’ve got to have deep respect for ethics, privacy and security,” he said.
He described Truveta’s workforce in 2021 as approximately two thirds technical and one third people with physician-scientist, clinical-informatics or epidemiology profiles. That was his approximate description of one organization at that time, not a verified current headcount or a universal staffing target. The broader leadership lesson is that handling health data calls for expertise and governance suited to the sensitivity of the information, not technology skill alone.
Free tools Windows power users keep installed
One-click scans. No signup required.
Best Value
What these career transitions do—and do not—show
The four stories support several grounded takeaways: a tech leader can contribute while learning the science; formal coursework, paper reading and asking colleagues are complementary ways to close knowledge gaps; interdisciplinary respect matters; and health-data work demands unusually careful stewardship. They do not establish that every software founder can become a biotech CEO, that a particular training path is sufficient, or that a technology-led approach will produce better scientific or medical outcomes.
All financial figures and company milestones in the 2021 feature are historical reports, not current business updates. GeekWire reported that Isilon sold to EMC for $2.25 billion in 2010; that insitro had raised $400 million in March 2021; and that Truveta had recently raised $95 million as of the feature’s publication. It also reported Jain’s expectation that Viome would generate $100 million in the following year, a projection at the time rather than a verified result. The feature cited PitchBook for U.S. biotech and pharma funding of $20 billion across 596 deals in the first half of 2021, compared with $27.2 billion across 1,043 deals in 2020; these are figures as GeekWire attributed them in 2021, not a current market comparison. Read the GeekWire feature.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
